
Neurodiversity at Work: Addressing ADHD’s Impact on Employees and Employers
Recorded On: 01/28/2025
-
Register
- Employer Member - Free!
- Health Industry Partner Member - Free!
ADHD affects an estimated 15.5 million U.S. adults, yet it remains one of the most underdiagnosed and undertreated neurodivergent conditions. As awareness grows, addressing ADHD in the workplace has become a critical priority for employers.
Join us for an insightful webinar where we will explore:
- How ADHD presents in adults and its impact on health care costs and overall employee well-being.
- The diagnosis process, access to care, and effective treatment strategies.
- Actionable approaches to reduce workplace challenges, including team training and tailored solutions for employees and their families.

David Sitt
Clinical Director
Agave Health

Ori Fruhauf
Chief Executive Officer
Agave Health

Pascal Goldschmidt
Chief Medical Officer
Lennar Corporation
